Transoesophageal echocardiography as complementary imaging during pulsed field ablation of atrial fibrillation: a practical step-by-step approach

European Heart Journal - Imaging Methods and Practice

2 September 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Atrial Fibrillation (AF) IMAGING Echocardiography

Abstract

AbstractAims

Transoesophageal echocardiography (TOE) provides real-time soft-tissue anatomical information during pulsed field ablation (PFA) of atrial fibrillation. This focused technical report describes a standardized workflow in which TOE complements, rather than replaces, fluoroscopic, and angiographic guidance throughout the procedure.

Technique

The workflow is organized into four consecutive phases: pre-procedural assessment, transseptal puncture, ablation–catheter configuration and positioning at the pulmonary vein ostia, and post-procedural assessment. Pre-procedural TOE focuses on exclusion of left atrial appendage thrombus, definition of pulmonary vein anatomy, assessment of the interatrial septum, and baseline evaluation for pericardial effusion. During transseptal access, orthogonal bicaval and short-axis views support puncture-site selection and continuous visualization of septal tenting, while fluoroscopy remains integral to guidewire and transseptal-system manipulation. During ablation, TOE complements fluoroscopic/angiographic guidance by depicting catheter configuration and its relationship with the pulmonary vein ostia and adjacent soft-tissue structures. At procedure completion, TOE is used to assess the iatrogenic interatrial septal defect and to exclude new pericardial effusion.

Conclusion

TOE should be considered a complementary imaging modality during fluoroscopy- and angiography-guided PFA rather than a replacement for these techniques. Its principal contribution is real-time visualization of soft-tissue anatomy, transseptal puncture, catheter–tissue relationships, and immediate post-procedural complications. Prospective studies are required to quantify its incremental clinical value.

Contributors

Federico Marchini
Federico Marchini

Author

Ferrara University Hospital Ferrara , Italy

Luca Canovi
Luca Canovi

Author

Vrije University Brussels Brussels , Belgium

Matteo Bertini
Matteo Bertini

Author

University Hospital of Ferrara Ferrara , Italy

Rita Pavasini
Rita Pavasini

Author

University Hospital of Ferrara Ferrara , Italy